Issels® Immunotherapy for Cancer has the longest track record with the clinical administration of non-toxic cancer vaccines to advanced and therapy-resistant cancers, achieving remarkable recurrence-free tumor remissions for years and even decades.
Issels ® Immunotherapy focuses with the same importance on destroying cancer cells and tumors as on altering the body’s internal environment that has been promoting the cancer growth.
Therefore, Issels ® Immunotherapy uses a cancer vaccine not on its own as a monotherapy. It integrates the vaccine and cell therapies that activate the cellular immunity, into the immunobiologic core treatment in order to also activate the various other levels of the body’s very complex defense mechanisms.
The Issels cancer vaccine and cell therapies cultured from the patient’s own immune cells are non-toxic and do not have any adverse side effects. This is in contrast to several chemically prepared drugs that are labeled as “immunotherapy” because they affect the immune system, but have been shown to cause serious life-threatening auto-immune reactions with a great variety of patients.
Issels doctors’ expertise and many years of extensive experience with the successful integration of the two pillars of a personalized non-toxic Immunotherapy for Cancer play a decisive role in the treatment outcomes.